Abiopharma

UTHR: United Therapeutics Corporation Announces FDA Approval of theLungFX™ Device for Centralized Ex Vivo Lung Perfusion

Mandatory Warrant Exercise :

Mandatory Warrant Exercise :

Mandatory Warrant Exercise :

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Notification Form for Director in respect of Interests in Securities

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Lim Wee Kian

Financial Statements and Related Announcement: Profit Guidance

General Announcement: Notice to Warrantholders - Expiry of Warrants on 29 June 2026

Walker & Dunlop Arranges $191 Million Refinance for Office Portfolio Throughout Netherlands

Diana Shipping Inc. Announces Extension of Tender Offer for All Outstanding Shares of Genco Shipping & Trading